Currently, little is known about the MR1/MAIT cell axis in neurological diseases with limited investigation into only five neurological diseases including glioma [15], MS [11, 12, 41], ischemia [42], experimental autoimmune encephalomyelitis [10], and cerebral palsy [43]. This evidence concerns the gene MR1 and central nervous system cancer.